Genetic suppression of ENH efficiently attenuates the migration, invasion, and proliferation of several cancer cells.[30] Additionally, ENH upregulation has been linked to tumor resistance to EGFR‐TKIs, as seen in NSCLC.[31] These results indicate that targeting ENH could be an effective anti‐tumor strategy. This evidence concerns the gene PDLIM5 and neoplasm.